Product Images Icatibant

View Photos of Packaging, Labels & Appearance

Figure 2 Time to 50% reduction from baseline in 3-item VAS score - icatibant fig1
Figure I - icatibant fig10
Figure J - icatibant fig11
Figure K - icatibant fig12
Figure L - icatibant fig13
Figure M - icatibant fig14
Figure N - icatibant fig15
Figure O - icatibant fig16
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-30 mg per 3 mL (10 mg/mL) - Syrine Label - icatibant fig17
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-30 mg per 3 mL (10 mg/mL) - Syringe Carton (1 Syringe) - icatibant fig18
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-30 mg per 3 mL (10 mg/mL) - Syringe-Carton (3 Syringes) - icatibant fig19
Figure A - icatibant fig2
Figure B - icatibant fig3
Figure C - icatibant fig4
Figure D - icatibant fig5
Figure E - icatibant fig6
Figure F - icatibant fig7
Figure G - icatibant fig8
Figure H - icatibant fig9
Chemical Structure - icatibant str

Product Label Images

The following 20 images provide visual information about the product associated with Icatibant NDC 55150-351 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 2 Time to 50% reduction from baseline in 3-item VAS score - icatibant fig1

Figure I - icatibant fig10

Figure J - icatibant fig11

Figure K - icatibant fig12

Figure L - icatibant fig13

Figure M - icatibant fig14

Figure N - icatibant fig15

Figure O - icatibant fig16

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-30 mg per 3 mL (10 mg/mL) - Syrine Label - icatibant fig17

Icatibant is a medication available in the form of an injection. Each injection contains 30 mg of the active ingredient per 3 mL, with a concentration of 10 mg/mL. This injection is intended for subcutaneous use only. The medication comes in a single-dose prefilled syringe with a capacity of 3 mL. It is manufactured in India for Eugia US LLC, based in E. Windsor, NJ 08520. The code displayed is TS/DRUGS/13/2010.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-30 mg per 3 mL (10 mg/mL) - Syringe Carton (1 Syringe) - icatibant fig18

This text appears to be from the packaging of a medication called Carlon. The medication is contained in a single-dose, prefilled syringe with a protective cap. It is indicated for subcutaneous use and each syringe delivers 30 mg of icatibant. The inactive ingredients include sodium chloride, glacial acetic acid, sodium hydroxide, and water for injection. The medication should be stored between 2° to 25°C and should not be frozen. The package insert contains full prescribing information, dosage, and administration instructions. The medication does not contain preservatives and the plunger rubber stopper is not made with natural rubber latex.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-30 mg per 3 mL (10 mg/mL) - Syringe-Carton (3 Syringes) - icatibant fig19

Figure A - icatibant fig2

This is a description for a pre-filled syringe with a protective cap over the syringe tip. It may come with an alcohol wipe, but the wipe is not included in the carton.*

Figure B - icatibant fig3

Figure C - icatibant fig4

Figure D - icatibant fig5

Figure E - icatibant fig6

Figure F - icatibant fig7

Figure G - icatibant fig8

Figure H - icatibant fig9

Chemical Structure - icatibant str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents